What You Need To Know About Infectious Disease
Prevention & Treatment
International Cooperation
National borders are trivial impediments to infectious disease threats. In the highly interconnected and readily traversed global village of our time, one nation’s problem soon becomes every nation’s problem. Therefore, strategies must be implemented worldwide, not just nationally, in order to have a true impact.
Explore Other Topics
What do you know about infectious disease?
The 1918 influenza pandemic (the so-called “Spanish” flu) is estimated to have killed how many people worldwide?
-
Sorry, that’s incorrect.
The 1918 influenza pandemic is estimated to have killed between 50 million and 100 million people worldwide. Many of those deaths were due to the effects of pneumococcal pneumonia, a secondary complication of flu for which no antibiotics existed in 1918.
-
Sorry, that’s incorrect.
The 1918 influenza pandemic is estimated to have killed between 50 million and 100 million people worldwide. Many of those deaths were due to the effects of pneumococcal pneumonia, a secondary complication of flu for which no antibiotics existed in 1918.
-
Correct!
The 1918 influenza pandemic is estimated to have killed between 50 million and 100 million people worldwide. Many of those deaths were due to the effects of pneumococcal pneumonia, a secondary complication of flu for which no antibiotics existed in 1918.
Infectious Disease Defined
- Pandemic
An increase in the occurrence of a particular disease over a very large region, such as a continent or the entire globe, that is greater than what is expected over a given period of time.
National Academies
Search the National Academies Press website by selecting one of these related terms.
Source Material
- Infectious Disease Movement in a Borderless World—Workshop Summary (2010)
- Global Issues in Water, Sanitation, and Health—Workshop Summary (2009)
- Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases (2009)
- The U.S. Commitment to Global Health: Recommendations for the Public and Private Sectors (2009)
- Achieving Sustainable Global Capacity for Surveillance and Response to Emerging Diseases of Zoonotic Origin—Workshop Summary (2008)
- Global Infectious Disease Surveillance and Detection: Assessing the Challenges, Finding Solutions—Workshop Summary (2007)
- Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance (2004)